(HealthDay)—A public meeting on cannabidiol (CBD) products will be held Friday by the U.S. Food and Drug Administration, with the goal of gathering information on products that contain CBD.
CBD products are increasingly popular and include items such as oils, capsules, lotions, and gummies.
The meeting is the first FDA public meeting on CBD and the first step toward regulating it, NBC News reported. The dozens of scheduled speakers at the meeting include doctors, consumers, and cannabis industry members, NBC News reported.
Source: Read Full Article